Amprius Technologies (NYSE:AMPX) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Amprius Technologies (NYSE:AMPXGet Free Report) released its earnings results on Wednesday. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02), Zacks reports. Amprius Technologies had a negative return on equity of 18.16% and a negative net margin of 43.98%.The business had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million. Amprius Technologies updated its FY 2026 guidance to –0.060 EPS.

Amprius Technologies Stock Performance

Amprius Technologies stock traded up $0.53 during mid-day trading on Friday, reaching $16.64. The stock had a trading volume of 9,180,816 shares, compared to its average volume of 8,861,354. Amprius Technologies has a fifty-two week low of $2.32 and a fifty-two week high of $22.80. The stock’s 50-day simple moving average is $17.53 and its 200-day simple moving average is $13.25. The firm has a market capitalization of $2.28 billion, a PE ratio of -55.41 and a beta of 2.20.

Key Headlines Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

Analyst Upgrades and Downgrades

AMPX has been the subject of several recent analyst reports. Craig Hallum raised their target price on Amprius Technologies from $17.00 to $21.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Cantor Fitzgerald raised their target price on Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. Needham & Company LLC reaffirmed a “buy” rating and set a $20.00 target price on shares of Amprius Technologies in a research note on Tuesday, March 10th. Roth Mkm reaffirmed a “buy” rating on shares of Amprius Technologies in a research note on Friday. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Amprius Technologies in a research note on Monday, April 20th. Eight research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.

View Our Latest Stock Analysis on Amprius Technologies

Insider Buying and Selling

In other news, Director Wen Hsuan Hsieh sold 413,146 shares of the firm’s stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $18.44, for a total value of $7,618,412.24. Following the transaction, the director owned 44,444 shares in the company, valued at $819,547.36. This trade represents a 90.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kang Sun sold 1,500,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total value of $23,865,000.00. Following the completion of the transaction, the director owned 1,342,400 shares in the company, valued at $21,357,584. This represents a 52.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 2,539,829 shares of company stock worth $42,323,376 over the last three months. Company insiders own 12.90% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Alberta Investment Management Corp bought a new position in shares of Amprius Technologies in the fourth quarter valued at approximately $1,001,000. Vident Advisory LLC bought a new stake in Amprius Technologies during the fourth quarter worth $107,000. Summit Securities Group LLC bought a new stake in Amprius Technologies during the fourth quarter worth $54,000. Numerai GP LLC lifted its holdings in Amprius Technologies by 29.1% during the fourth quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock worth $759,000 after acquiring an additional 21,698 shares during the period. Finally, Osterweis Capital Management Inc. lifted its holdings in Amprius Technologies by 142.6% during the fourth quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock worth $3,589,000 after acquiring an additional 267,385 shares during the period. Institutional investors own 5.04% of the company’s stock.

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Further Reading

Earnings History for Amprius Technologies (NYSE:AMPX)

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.